Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Dragonfly Therapeutics
Dragonfly Therapeutics
BMS returns $475M IL-12 oncology asset to Dragonfly’s pond
Fierce Biotech
Mon, 02/6/23 - 06:12 pm
Dragonfly Therapeutics
Bristol Myers Squibb
oncology
DF6002
solid tumors
Gilead dives deeper into NK cell therapies with Dragonfly deal
Pharmaforum
Tue, 05/3/22 - 10:37 am
Gilead Sciences
natural killer cells
Dragonfly Therapeutics
TriNKET
cancer
Bristol Myers Squibb pens $475M Dragonfly pact for IL-12 program
Fierce Biotech
Mon, 08/17/20 - 10:34 am
Bristol-Myers Squibb
Dragonfly Therapeutics
IL-12 immunotherapy
DF6002
Bristol Myers Pays Dragonfly $55M to Bring NK Cells to Neuro Diseases
Xconomy
Mon, 07/6/20 - 10:48 am
Bristol-Meyers Squibb
Dragonfly Therapeutics
multiple sclerosis
MS
neuroinflammation
Smaller groups await Bristol-Myers Squelgene fallout
EP Vantage
Wed, 01/16/19 - 11:53 am
M&A
Bristol-Myers Squibb
Celgene
Vividion Therapeutics
Evotec
Prothena
Anokion
Skyhawk Therapeutics
Dragonfly Therapeutics
BeiGene
Agios Pharmaceuticals
Jounce Therapeutics
Little Dragonfly bursts onto the I/O scene with a $33M Celgene deal and some of the biggest names in biotech
Endpoints
Mon, 06/12/17 - 09:44 am
Dragonfly Therapeutics
immuno-oncology
Celgene